Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen–Identical Sibling Transplants for Adults With Leukemia
Theresa Hahn(Roswell Park Comprehensive Cancer Center), Olle Ringdén(Karolinska Institutet), Stephen Pavletic(Mount Sinai Hospital), Vijay Reddy(University of Florida), Pierre Tiberghien(Inserm), Luis Isola(Mount Sinai Medical Center), Mukta Arora(Fairview Health Services), John Horan(Emory University), Claudio Anasetti(Moffitt Cancer Center), Philip L. McCarthy(Roswell Park Comprehensive Cancer Center), Vikas Gupta(Indian Institute of Technology Kanpur), Richard T. Maziarz(Oregon Health & Science University), Mark R. Litzow(Mayo Clinic in Arizona), Robert Peter Gale(Imperial College London), Dan Wang(Tianjin University of Traditional Chinese Medicine), Jon J. van Rood(Leiden University Medical Center), Mei-Jie Zhang(Medical College of Wisconsin), Joerg Halter(University Hospital of Basel), Gregory A. Hale(Johns Hopkins University), Haydar Frangoul(Children’s Hospital at TriStar Centennial)
Cited by 204
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
|New England Journal of Medicine|2020|1.8k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k